By Business/Source
Currency:CNY
2024/FY
Stock NameRevenueRatio
Research, development, production and sale of biopharmaceutical products2.12B100.00%
By Country/Region
Currency:CNY
2024/FY
Stock NameRevenueRatio
Mainland China1.88B88.42%
United States of America (The USA)243.64M11.47%
Other regions2.26M0.11%